Patients with Williams syndrome exhibit a range of phenotypes, most notable of which are supravalvular aortic stenosis (SVAS), a specific cognitive profile, mental retardation/developmental delay, typical 'elfin' facial features, idiopathic infantile hypercalcemia and inguinal hernia [3] . The main clinical feature of SVAS is narrowing of the large elastic arteries, which compromises blood flow. The specific cognitive profile in Williams syndrome includes pronounced auditory and language rote memory, a gregarious personality and impaired visuospatial constructive cognition -an inability to see objects or pictures as being made up of separate parts and therefore to reconstruct objects when presented with their individual parts.
The elastin gene was one of the first to be identified as deleted from one chromosome in DNA isolated from patients with Williams syndrome. SVAS can be inherited as a distinct autosomal dominant trait, and a translocation break-point and a 30 kilobase deletion in the elastin gene on chromosome 7q11 were found in patients with SVAS who did not have the other phenotypic traits common to Williams syndrome [4, 5] . This directly implicated the elastin gene in SVAS, and because over 75 % of Williams syndrome patients have SVAS, it was a good candidate gene to be tested for rearrangement or deletion in Williams syndrome. A major breakthrough was reported in 1993 by Ewart et al. [6] , who showed that the elastin gene was missing from one chromosome (that is, it was hemizygous) in both familial and sporadic cases of Williams syndrome. Further studies showed that over 90 % of people with Williams syndrome had a deletion of one copy of the elastin gene [7, 8] . This suggested that hemizygous deletion of the elastin gene may be responsible for the vascular and connective tissue pathology of the Williams syndrome phenotype, including SVAS, inguinal hernias, premature aging of the skin and some of the facial dysmorphic features. However, as none of the patients with a diagnosis of solely SVAS had neurodevelopmental abnormalities, the specific cognitive profile and general mental retardation seen in Williams syndrome could not be easily explained by hemizygous deletion of the elastin gene. So, the hunt continued for other genes in the vicinity of the elastin gene that could be involved in the neural defects seen in Williams syndrome.
The search for candidate genes was guided by two mouse models involving the knockout of protein kinase genes. One was a mouse mutant in the nonreceptor tyrosine kinase fyn [9] , and the second was a 'knockout' of the ␥ subtype of the calcium-and phospholipid-dependent protein kinase C (PKC␥) [10, 11] . Both murine gene disruptions reduced long-term potentiation (LTP), a cellular phenomenon that is thought to be involved in synaptic plasticity of neurons in the hippocampus, and hence in memory. Moreover, the mice with reduced LTP also had impaired spatial learning, strengthening the functional link between LTP and learning and memory. As both of the genes disrupted in the mouse models were protein kinases, the University of Utah group who were hunting for candidate genes for the cognitive aspects of Williams syndrome tested genomic DNA in the vicinity of the elastin gene for genes encoding conserved tyrosine kinase domains [2] . They used the polymerase chain reaction (PCR) to amplify a 315 base-pair sequence from a cosmid adjacent to the elastin gene, and so identified an open reading frame 100 % identical to part of the LIM-Kinase1 (LIMK1) gene. LIMK1 has a protein kinase domain and also has LIM-type putative zinc-binding domains, which have been found in a number of developmentally important genes (such as lin-11, Isl-1 and mec-3, which give the domain its name) [12, 13] . A full-length LIMK1 cDNA clone was mapped to the region affected in the hemizygous deletions seen in Williams syndrome patients, adjacent to the elastin gene on chromosome 7q11.23.
The next piece of the puzzle was supplied by careful analysis of families with Williams syndrome, which allowed identification of rare cases which did not exhibit all of the typical phenotypic characteristics. Two families were identified [2] with 'partial Williams syndrome', which includes SVAS and the specific cognitive profile of impaired visuospatial constructive cognition, but not the characteristic facial features, hypercalcemia or mental retardation. Further molecular analysis revealed that DNA from members of these two families had hemizygous deletions of about 300 kilobases and 84 kilobases, respectively. The 300 kilobase deletion removed both the elastin and LIMK1 genes, whereas the 84 kilobase deletion removed only the 3 ′ end of the elastin gene and the complete LIMK1 gene (Fig. 1) . To ensure that no other genes mapped to the deleted region, the Utah group sequenced the genomic DNA contained within the 84 kilobase deletion and found no evidence for any other transcribed sequences [2] . This suggested that the specific visuospatial constructive cognitive deficit seen in Williams syndrome could be due to the hemizygous deletion of the LIMK1 gene, whereas the SVAS and connective tissue pathology was due to deletion of the elastin gene (Fig. 1) . Furthermore, they checked the expression of the elastin gene by Northern blot analysis, which revealed little or negligible expression in fetal and adult brain yet strong expression in adult heart and pancreas and in fetal lung. The LIMK1 gene was found to be expressed ubiquitously in all fetal and adult tissues, with the highest level in brain. In situ hybridization analysis of LIMK1 in human embryos showed expression in the developing brain.
The evidence overall is strong for the role of elastin in SVAS and the connective tissue pathology seen in Williams syndrome, especially as there are patients with only SVAS who have specific disruptions of elastin gene sequences. The role of the LIMK1 gene in the visuospatial constructive cognitive defect seen in Williams syndrome is at this stage suggestive but not decisive. Deletions and other chromosomal rearrangements can cause position effects on the expression of genes whose coding sequences are quite distant from the deleted region (up to hundreds of kilobases away); these effects can be due to several causes, one of which is the removal of locus control regions that exert long-distance control of expression and chromatin domains (see [14] for review). All of the current evidence for the role of LIMK1 in the cognitive defect seen in Williams syndrome is based on the analysis of one patient with an 84 kilobase deletion, and the correlated findings that removal of two different protein kinases in mice disrupted spatial learning. More deletion break-points are needed to determine the precise critical interval for the specific cognitive profile in Williams syndrome. This may be difficult to achieve, however, as most patients have deletions greater than 500 kilobases and the Utah group screened hundreds of patients to identify the two families with partial Williams syndrome.
A complete transcript map of the region surrounding the elastin and LIMK1 genes also needs to be completed, to see whether there are other genes that could be involved by a position effect. Also, there are several examples of syndromes in which double deletions or deletions coupled to chromosomal inversions have occurred, thereby giving false information on the location of the critical interval for a specific disease. A complete physical and transcript map of the Williams syndrome region would provide more information on the possibility of a complex rearrangement in the family segregating the 84 kilobase deletion. It would also provide more genes as candidates for the other features of the full Williams syndrome phenotype (including characteristic facial features, hypercalcemia and mental retardation/developmental delay; see Fig. 1 ). Mutations which specifically disrupt the LIMK1 gene in patients with visuospatial constructive cognitive defect would be the most compelling evidence, but patients with these specific deficits will be difficult to find. Mouse models for disruption of the LIMK1 gene will also be essential for determining its role in neural development and spatial learning. But we have already been presented with an important and exciting dissection of the Williams syndrome phenotype, which has important implications for other studies of specific candidate genes; we must now await further developments. 
